market
riddle
Activity
Companies
Insiders
Institutions
Pricing
EN
Sign in
Sign up
Institutions
/
Great Point Partners, LLC
/ Move history
‹
Back to Great Point Partners, LLC
GP
Great Point Partners, LLC
Quarter-over-quarter position changes
38 changes
All actions
All impact
Action
Company
Quarter
↓
Δ shares
Δ %
Held after
Flow
Impact
New
Sol-Gel Technologies Ltd
Mar 31, 2026
+274,363
New
274,363
$21.74M
medium
Exited
Disc Medicine, Inc.
IRON
Mar 31, 2026
-250,000
-100%
0
$19.85M
medium
Exited
75382E208
Mar 31, 2026
-581,187
-100%
0
$19.68M
medium
New
ALUMIS INC.
ALMS
Mar 31, 2026
+856,061
New
856,061
$18.86M
medium
Exited
SOLENO THERAPEUTICS, INC.
Mar 31, 2026
-400,000
-100%
0
$18.52M
medium
New
BRIGHT MINDS BIOSCIENCES INC.
Mar 31, 2026
+220,000
New
220,000
$16.05M
medium
Exited
Dianthus Therapeutics, Inc.
Mar 31, 2026
-350,000
-100%
0
$14.42M
medium
New
Annexon, Inc.
Mar 31, 2026
+2,500,000
New
2,500,000
$13.85M
medium
New
Zenas BioPharma, Inc.
ZBIO
Mar 31, 2026
+524,066
New
524,066
$10.25M
medium
New
MoonLake Immunotherapeutics
MLTX
Mar 31, 2026
+500,000
New
500,000
$9.32M
medium
Exited
Fulcrum Therapeutics, Inc.
Mar 31, 2026
-800,000
-100%
0
$9.05M
medium
Exited
Upstream Bio, Inc.
UPB
Mar 31, 2026
-300,000
-100%
0
$8.14M
medium
New
Vera Therapeutics, Inc.
Mar 31, 2026
+199,348
New
199,348
$8.02M
medium
Added
NEKTAR THERAPEUTICS
Mar 31, 2026
+105,721
+50%
316,453
$7.61M
medium
New
LB PHARMACEUTICALS INC
LBRX
Mar 31, 2026
+300,000
New
300,000
$7.40M
medium
New
Compass Therapeutics, Inc.
Mar 31, 2026
+1,350,000
New
1,350,000
$7.14M
medium
New
SCYNEXIS, Inc.
Mar 31, 2026
+7,554,347
New
7,554,347
$6.93M
medium
Exited
Ultragenyx Pharmaceutical Inc.
Mar 31, 2026
-300,000
-100%
0
$6.90M
medium
Added
Vor Biopharma Inc.
Mar 31, 2026
+379,893
+28%
1,750,000
$6.78M
medium
Trimmed
Context Therapeutics Inc.
Mar 31, 2026
-2,445,215
-52%
2,238,496
$6.41M
medium
New
PALISADE BIO, INC.
Mar 31, 2026
+3,405,757
New
3,405,757
$5.96M
medium
New
Relmada Therapeutics, Inc.
Mar 31, 2026
+842,106
New
842,106
$5.86M
medium
New
Tenax Therapeutics, Inc.
Mar 31, 2026
+327,307
New
327,307
$5.23M
medium
Trimmed
Immunovant, Inc.
IMVT
Mar 31, 2026
-204,375
-27%
545,625
$5.08M
medium
Trimmed
Cullinan Therapeutics, Inc.
Mar 31, 2026
-334,032
-53%
300,000
$4.75M
low
New
ProMIS Neurosciences, Inc.
Mar 31, 2026
+371,402
New
371,402
$4.72M
low
New
Immix Biopharma, Inc.
Mar 31, 2026
+350,000
New
350,000
$3.19M
low
Added
Neurogene Inc.
NGNE
Mar 31, 2026
+150,000
+43%
500,000
$3.02M
low
Exited
Sana Biotechnology, Inc.
Mar 31, 2026
-700,000
-100%
0
$2.85M
low
Added
Climb Bio, Inc.
CLYM
Mar 31, 2026
+354,596
+36%
1,334,130
$2.43M
low
Added
Zura Bio Limited
Mar 31, 2026
+400,000
+10%
4,215,930
$2.38M
low
New
44486Q103
Mar 31, 2026
+3,750,000
New
3,750,000
$2.28M
low
Added
JADE BIOSCIENCES, INC.
Mar 31, 2026
+158,189
+20%
964,462
$2.22M
low
New
Alkermes plc.
Mar 31, 2026
+50,000
New
50,000
$1.77M
low
New
Opus Genetics, Inc.
Mar 31, 2026
+324,340
New
324,340
$1.48M
low
Added
Silence Therapeutics plc
SLN
Mar 31, 2026
+212,457
+26%
1,020,489
$1.12M
low
Trimmed
KalVista Pharmaceuticals Inc
Mar 31, 2026
-10,632
-1.6%
675,000
$214.0K
low
Added
Contineum Therapeutics, Inc.
Mar 31, 2026
+198
+0.0%
800,198
$2.6K
low
← Prev
Page 1 of 1
Next →